Stephana Patton
General Counsel
publicly-traded biotechnology
BioTime
Cambodia
Biography
Stephana Patton, Ph.D., J.D. joined BioTime as General Counsel in February 2017. Stephana brings more than 17 years of experience creating portfolio value at publicly-traded biotechnology and pharmaceutical companies. She was formerly the General Counsel and Commercial Compliance Officer at BioDelivery Sciences, a publicly-traded specialty pharmaceutical company. Prior to BioDelivery Sciences, she held various senior management positions, including leading Intellectual Property (IP) and Licensing at Salix Pharmaceuticals, a global pharmaceutical company that was acquired for $11.2 Billion in 2015. Prior to joining Salix, Stephana was in private practice at a large international law firm known for its IP and corporate securities practices. Her practice focused on counseling clients on IP-related matters as well as licensing transactions for biotechnology and pharmaceutical companies at varying stages of product development. Dr. Patton earned a Juris Doctor (J.D.) degree from the Boston University School of Law and a Ph.D. in Biochemistry, Cell and Developmental Biology from Emory University.
Research Interest
biotechnology and pharmaceutical
